Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine

NCT07374510 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL: high-dose Group ACYW135X Meningococcal Conjugate Vaccine
BIOLOGICAL: medium-dose Group ACYW135X Meningococcal Conjugate Vaccine
BIOLOGICAL: low-dose Group ACYW135X Meningococcal Conjugate Vaccine
BIOLOGICAL: Group ACYW135 Meningococcal Conjugate Vaccine (CRM197)
BIOLOGICAL: Placebo

Sponsor

Sinovac Life Sciences Co., Ltd.